Glenmede Trust’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-1,906
Closed -$246K – 1986
2020
Q3
$246K Sell
1,906
-7
-0.4% -$920 ﹤0.01% 978
2020
Q2
$215K Buy
1,913
+914
+91% +$93.8K ﹤0.01% 988
2020
Q1
$101K Hold
999
– – ﹤0.01% 1413
2019
Q4
$101K Sell
999
-1,254
-56% -$124K ﹤0.01% 1413
2019
Q3
$230K Sell
2,253
-499
-18% -$50.9K ﹤0.01% 1112
2019
Q2
$319K Sell
2,752
-695
-20% -$74.8K ﹤0.01% 1030
2019
Q1
$362K Buy
3,447
+1,425
+70% +$160K ﹤0.01% 980
2018
Q4
$227K Sell
2,022
-402
-17% -$49.6K ﹤0.01% 1069
2018
Q3
$391K Buy
2,424
+1,244
+105% +$176K ﹤0.01% 950
2018
Q2
$140K Buy
1,180
+590
+100% +$72.2K ﹤0.01% 1162
2018
Q1
$60K Hold
590
– – ﹤0.01% 1561
2017
Q4
$60K Hold
590
– – ﹤0.01% 1561
2017
Q3
$47K Hold
590
– – ﹤0.01% 1674
2017
Q2
$30K Hold
590
– – ﹤0.01% 1784
2017
Q1
$30K Buy
590
+65
+12% +$3.44K ﹤0.01% 1784
2016
Q4
$26K Sell
525
-175
-25% -$9.18K ﹤0.01% 1829
2016
Q3
$41K Sell
700
-95
-12% -$5.47K ﹤0.01% 1680
2016
Q2
$45K Buy
795
+71
+10% +$4.74K ﹤0.01% 1611
2016
Q1
$55K Buy
724
+24
+3% +$1.55K ﹤0.01% 1492
2015
Q4
$44K Hold
700
– – ﹤0.01% 1609
2015
Q3
$46K Hold
700
– – ﹤0.01% 1609
2015
Q2
$47K Hold
700
– – ﹤0.01% 1651
2015
Q1
$49K Sell
700
-19
-3% -$1.29K ﹤0.01% 1689
2014
Q4
$48K Buy
719
+19
+3% +$1.25K ﹤0.01% 1764
2014
Q3
$48K Sell
700
-168
-19% -$13.1K ﹤0.01% 1704
2014
Q2
$71K Buy
868
+25
+3% +$1.69K ﹤0.01% 1532
2014
Q1
$57K Sell
843
-21
-2% -$1.56K ﹤0.01% 1613
2013
Q4
$61K Sell
864
-400
-32% -$31K ﹤0.01% 1566
2013
Q3
$96K Hold
1,264
– – ﹤0.01% 1389
2013
Q2
$82K Buy
+1,264
New +$67.9K ﹤0.01% 1384

Other funds holding PRLB

Glenmede Trust's PRLB Position: Q4 2020 in Review

Glenmede Trust sold out of Protolabs (PRLB) in Q4 2020, closing a stake of 1,906 shares — an estimated $246K sold.

Glenmede Trust first reported a position in PRLB in Q2 2013 and held it in 30 quarters. The position peaked at $391K in Q3 2018. 305 funds tracked by Wall St. Rank hold PRLB as of Q4 2020.

  • Glenmede Trust reported no remaining Protolabs position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 1,906 Protolabs shares in Q4 2020, an estimated $246K.
  • Glenmede Trust first reported a position in Protolabs in Q2 2013 and held it in 30 quarters.
  • Glenmede Trust's Protolabs position peaked at $391K in Q3 2018.
  • 305 funds tracked by Wall St. Rank held Protolabs as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.